
NTI Vice President Deborah Rosenblum discusses radiological risks at International Forum of Terrorism Risk (Re)insurance Pools

Today, NTI Executive Vice President
Deborah Rosenblum discussed radiological risks at a meeting in Paris of the
International Forum of Terrorism Risk (Re)insurance Pools. Rosenblum addressed
representatives of the insurance and reinsurance industries, as well as
government officials and industry representatives, on a conference panel
titled, “New Threats, Hyper-Terrorism and Possible Mitigation of Exposures. She
spoke about current risks and vulnerabilities of high-activity radioactive
sources, particularly the cesium-137 in hospital blood irradiators, and
emphasize security gaps and the potential consequences of a radioactive “dirty
bomb.”
Reducing radiological risks is a
core priority for NTI, in partnership with hospitals, governments and the
private sector—in the United States and globally—to raise awareness about
the risks posed by cesium-137 and other dangerous isotopes that could be stolen
and used to build a dirty bomb. NTI encourages the use, where feasible,
of safe and effective alternative technologies for eliminating the threat
permanently.
Read more about NTI’s work on this
issue:
- Preventing a Dirty Bomb: Engaging Hospitals, Industry and Governments
on Radiological Risks (Project
Page) - Preventing a Dirty Bomb: Effective Alternative Technologies
for Radiological Security (Brochure) - Dealing with the Double-Edged Sword of Cesium Blood Irradiation (Analysis & illustrative Story Map by CNS)
- NTI and State of California Partner to Reduce Radiological
“Dirty Bomb” Risks - Pool Re and the Nuclear Threat Initiative Highlight
Radiological Security Efforts
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News

NTI | bio Convenes International Experts for Annual Meeting on Biosecurity Risk Reduction
NTI | bio convened the annual Biosecurity Innovation and Risk Reduction Initiative (BIRRI) meeting from May 31 to June 2 at Downing College in Cambridge, United Kingdom.

New Report Recommends Biosecurity Safeguards for Benchtop DNA Synthesis Devices
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.

NTI | bio Partners with Carnegie India for the 2022 Global Tech Summit as India Assumes the G20 Presidency
NTI | bio partnered with Carnegie India as a "knowledge partner" for the 2022 Global Technology Summit and led two sessions on global biosecurity and biosafety.